March is National Nutrition Month, and it’s the perfect time to explore products that support your health and wellness j ...

Targeting final FDA approval of YUTREPIA™ after expiration of regulatory exclusivity on May 23, 2025Advancing pipeline of inhaled treprostinil ...

Virpax Pharmaceuticals, Inc. ("Virpax" or the "Company") a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) ...